RhoVac | Business Coach | Oncology | Pharma partnering | Deal making | Communication
RhoVac was an R&D company developing a unique prostate cancer therapy, targeting metastatic cells to prevent cancer recurrence and progression after primary tumor therapy.
RhoVac obtained a Horizon 2020 (EIC Accelerator) grant and hereby obtained access to Business Coaching. RhoVac’s CEO selected me as Business Coach. Each of the sessions were prepared and researched to cover the following aspects in CEO-dialogue:
Value proposition for the clinical applications and patient types of lead drug candidate
External communication channels and messages
Key value drivers for big pharma partners
Extract maximum value from engagement of transaction advisor
Identify trade-offs between deal type alternatives
Identify and apply “irrational factors” to enhance deal making
Identify alternatives to unattractive deal offers
Identify multi-indication strategies to increase drug asset value
How to break challenging news to stakeholders
Testimonial is available from RhoVac’s CEO.